Inpharmica
2015
FOUNDED
PRIVATE
STATUS
Early Stage VC
LATEST DEAL TYPE
1
INVESTORS
Description
Developer of a bio-medicine technology for designed to offer complex painkiller drug development. The company's bio-medicine technology is used in performing phase III of clinical studies on an increased number of patients, including the monitoring of undesired effects and development of documentation to register a new complex pain killer patented, enabling patients to access next generation pain-killers.
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Other Healthcare Services
Other Industries
Biotechnology
Primary Office
- ul. Czerwonych Maków 12 lok. 13
- Warszawa, Mazowieckie 01-493
- Poland
+48 600 000 000
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore Inpharmica’s full profile, request a free trial.
Inpharmica Valuation and Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Early Stage VC | Completed | Startup |
Inpharmica Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Board Seat |
Contact Info |
|---|---|---|---|---|---|---|
| Black Pearls VC | Venture Capital | Minority | 000 0000 | 000000 0 |
Inpharmica Board Members (1)
| Name | Representing | Role | Since | Contact Info |
|---|---|---|---|---|
| Weronika Kiełczewska | Inpharmica | Chairman | 000 0000 |